Amphastar Pharmaceuticals (AMPH) News Today → The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad) Free AMPH Stock Alerts $41.00 +0.09 (+0.22%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLouisiana State Employees Retirement System Takes $1.16 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - April 24 at 4:54 AMCalamos Advisors LLC Takes Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - April 22 at 6:23 AMBrokers Issue Forecasts for Amphastar Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:AMPH)americanbankingnews.com - April 20 at 3:14 AMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Forecasted to Post FY2024 Earnings of $3.48 Per Sharemarketbeat.com - April 19 at 8:51 AMCapital One Financial Comments on Amphastar Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:AMPH)americanbankingnews.com - April 19 at 1:48 AMFederated Hermes Inc. Has $202.42 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - April 18 at 12:22 PMEquities Analysts Offer Predictions for Amphastar Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:AMPH)marketbeat.com - April 18 at 5:59 AMAmphastar Pharmaceuticals Poised for Growth: Strong Generic Pipeline and Strategic Marketing Drive Buy Ratingmarkets.businessinsider.com - April 18 at 12:59 AMNaloxone Market To Reach USD 2,478.6 Million By 2032 | DataHorizzon Researchfinance.yahoo.com - April 16 at 11:20 PMAmphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Up 3%marketbeat.com - April 15 at 5:31 PMShaker Investments LLC OH Increases Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - April 12 at 11:23 PMAmphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growthfinance.yahoo.com - April 12 at 1:45 PMAmphastar Pharmaceuticals' (AMPH) Hold Rating Reaffirmed at Needham & Company LLCmarketbeat.com - April 10 at 8:17 AMRaymond James & Associates Acquires 39,916 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - April 10 at 4:11 AMAmphastar Pharmaceuticals (NASDAQ:AMPH) Offers Savvy Value Investors a Window of Opportunitymsn.com - April 9 at 3:45 PMMoody Aldrich Partners LLC Invests $3.90 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - April 9 at 1:32 PMSG Americas Securities LLC Sells 42,008 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - April 5 at 4:08 AMAmphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Knowmsn.com - April 4 at 7:03 PMInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 500 Shares of Stockinsidertrades.com - April 4 at 7:09 AMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $21,715.00 in Stockmarketbeat.com - April 3 at 9:14 AMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by American Century Companies Inc.marketbeat.com - March 25 at 4:09 AMAnalysts’ Top Healthcare Picks: Soleno Therapeutics (SLNO), Optinose (OPTN)markets.businessinsider.com - March 18 at 7:02 PMWalleye Capital LLC Invests $1.83 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - March 18 at 4:18 AMAMPH Apr 2024 65.000 callfinance.yahoo.com - March 16 at 9:24 PMAMPH Apr 2024 60.000 putfinance.yahoo.com - March 16 at 9:24 PMMichael A. Zasloff Sells 12,500 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stockinsidertrades.com - March 16 at 8:56 AMJacobs Levy Equity Management Inc. Has $25.52 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - March 11 at 9:40 AMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Position Trimmed by Northern Trust Corpmarketbeat.com - March 9 at 4:59 AMAmphastar Pharmaceuticals Inc CFO, EVP & Treasurer William Peters Sells 18,136 Sharesfinance.yahoo.com - March 9 at 12:05 AMAnalysts Are Bullish on Top Healthcare Stocks: Oxford BioMedica (OXBDF), EyePoint Pharmaceuticals (EYPT)markets.businessinsider.com - March 8 at 1:09 AMAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down Following Insider Sellingmarketbeat.com - March 7 at 10:31 AMQube Research & Technologies Ltd Purchases 96,167 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - March 7 at 5:51 AMAmphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Sharesfinance.yahoo.com - March 6 at 11:56 PMAmphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conferencefinanznachrichten.de - March 6 at 6:56 PMJP Morgan Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Overweight Recommendationmsn.com - March 6 at 6:56 PMAmphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated by Analysts at JPMorgan Chase & Co.marketbeat.com - March 5 at 7:49 AMWhy Amphastar Pharmaceuticals Is A Strong Buy: Growth, Valuation, And Strategic Acquisitionsseekingalpha.com - March 4 at 5:52 PMInvesco Ltd. Sells 150,045 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - March 3 at 5:22 AMLLY Mar 2024 980.000 callca.finance.yahoo.com - March 2 at 11:06 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 2 at 1:05 PMAnalysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Schrodinger (SDGR)markets.businessinsider.com - February 29 at 8:21 AMQ4 2023 Amphastar Pharmaceuticals Inc Earnings Callfinance.yahoo.com - February 29 at 8:21 AMAlgert Global LLC Sells 34,560 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - February 29 at 6:33 AMAmphastar Pharmaceuticals Inc Reports Robust Revenue Growth and Strong Full-Year Performancefinance.yahoo.com - February 28 at 6:14 PMHere's what Wall Street expects from Amphastar Pharmaceuticals's earningsmarkets.businessinsider.com - February 27 at 3:34 PMAmphastar Pharmaceuticals (AMPH) to Release Quarterly Earnings on Wednesdaymarketbeat.com - February 27 at 7:27 AMEagle Asset Management Inc. Has $1.73 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - February 27 at 7:26 AMAgios Pharmaceuticals Stock Earns IBD Stock Upgrade Again, Hitting 90-Plus RS Ratingmsn.com - February 26 at 6:45 PMAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Charles Schwab Investment Management Inc.marketbeat.com - February 26 at 4:19 AMMonashee Investment Management LLC Takes Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)marketbeat.com - February 25 at 10:54 AM Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address The Hard Truth About Investing For Retirement (Ad)Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading. Click To Access This Powerful Training Right Now! AMPH Media Mentions By Week AMPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPH News Sentiment▼1.210.44▲Average Medical News Sentiment AMPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPH Articles This Week▼144▲AMPH Articles Average Week Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GERN News Today GLPG News Today PTCT News Today RNA News Today MRVI News Today KROS News Today CPRX News Today DYN News Today SNDX News Today SDGR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMPH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
